Razionale

Innovation. This is the word that will characterizes also the third Edition of the TOP5 Conference in Venice.

The event is aimed to identify, in the era of globalization, the ongoing and future challenges in infectious diseases and to bring current global issues to the attention of institutions.

The following topics will be covered:
- Methodology of clinical research and application of artificial intelligence to healthcare.
- Antimicrobial resistant microrganisms and optimal use of new available antibiotics.
- HIV treatment and prophylaxis. How to implement tailored therapeutic approaches.
- Emerging and re-emerging viral infections. New approaches for immunization and prevention of communicable infectious diseases.
- Fungal infections. New multidrug resistant fungi spread around the world and new drugs are needed to overcome resistance.

But what does “innovation” mean in Infectious Diseases? Innovation means “appropriate and rational use” of diagnostic methods, antimicrobials, Big Data and maching learning finalized to develop updated knowledge for the modern treatment of Infectious Diseases.

These issues will be discussed with academicians, stakeholders, professionals and young researchers to share experiences and evidences and to have an unforgettable experience in one of the most beautiful venue in the world: the ancient Venice!

Obiettivo Formativo

2 - Linee guida - protocolli - procedure

Responsabile Scientifico

PRESIDENT
Prof. Marco Falcone
Professor of Infectious Diseases
Department of Clinical and Experimental Medicine
University of Pisa,
Azienda Ospedaliero-Universitaria Pisana, Pisa (Italy)

SCIENTIFIC SECRETARIAT
Dr. Alberto Borghetti (Pisa, Italy)
Prof. Annamaria Cattelan (Padua, Italy)
Prof. Cristina Mussini (Modena, Italy)
Dr. Sandro Panese (Venice, Italy)
Dr. Giusy Tiseo (Pisa, Italy)

Faculty

Najy Alsayed - A. Menarini
Andrea Antinori - Rome, Italy
Massimo Antonelli - Rome, Italy
Gianmaria Baldin - Rome, Italy
Matteo Bassetti - Genoa, Italy
Federica Basso - Advanz Pharma
Elena Giovanna Bignami - Parma, Italy
Paolo Bonfanti - Monza, Italy
Alberto Borghetti - Pisa, Italy
Mara Campitiello - Ministero della Salute, Italy
Antonella Castagna - Milan, Italy
Annamaria Cattelan - Padua, Italy
Marco Cavaleri - Amsterdam, The Netherlands
Giovanni Cenderello - Sanremo, Italy
Elena Cimino - Pfizer
Andrea Coppola - Shionogi
Andrea Cossarizza - Modena, Italy
Francesco De Rosa - Turin, Italy
Gabriella D’Ettorre - Rome, Italy
Jan De Waele - Ghent, Belgium
Lennie Derde - Utrecht, The Netherlands
Antonio Di Biagio - Genoa, Italy
Giovanni Di Perri - Turin, Italy
Adrian Egli - Zürich, Switzerland
Marco Falcone - Pisa, Italy
Emanuele Focà - Brescia, Italy
Cecilia Fochesato - Milan, Italy
Gabriele Forcina - Gilead
Frances Garraghan - Manchester, UK
Ivan Gentile - Naples, Italy
Cristina Gervasoni - Milan, Italy
Maddalena Giannella - Bologna, Italy
Corrado Girmenia - Rome, Italy
Andrea Gori - Milan, Italy
Paolo Antonio Grossi - Varese, Italy
Ryan Hamilton - Leicester, UK
David Jenkins - Leicester, UK
Souha S. Kanj - Beirut, Lebanon
Leonard Leibovici - Tel Aviv, Israel
Andrea Lenzi - Presidente del CNR
Miriam Lichtner - Rome, Italy
Sergio Lo Caputo - Foggia, Italy
Giordano Madeddu - Sassari, Italy
Giulia Carla Marchetti - Milan, Italy
Claudio Maria Mastroianni - Rome, Italy
Francesco Menichetti - Perugia, Italy
Francesco Mennini - Ministero della Salute, Italy
Marianna Meschiari - Modena, Italy
Carlo Monti - AIFA - Ministero della Salute, Italy
Patricia Muñoz - Madrid, Spain
Cristina Mussini - Modena, Italy
Alessandra Oliva - Rome, Italy
Chloe Orkin - London, UK
Fausto Orsomarso - Commissione Finanze, Intergruppo Parlamentare Prevenzione e Controllo Malattie Infettive, Italy
Gerardo Palmiero - Pisa, Italy
Saverio Parisi - Padua, Italy
David Paterson - Singapore
Mical Paul - Haifa, Israel
Federico Pea - Bologna, Italy
Alessandro Perrella - Naples, Italy
Jean Paul Pirnay - Brussels, Belgium
Jason Pogue - Ann Arbor, USA
Gianluca Polifrone - Fondazione Biotecnopolo, Siena
Francesca Poma - IQVIA
Davide Pugliese - Viatris
Massimo Puoti - Milan, Italy
Jordi Rello - Barcelona, Spain
Marco Ridolfi - Rome, Italy
Caterina Rizzo - Pisa, Italy
Jesus Rodriguez Baño - Seville, Spain
Alessandro Russo - Catanzaro, Italy
Claudia Sala - Siena, Italy
Elisa Sangiorgi - Regione Emilia Romagna; AIFA
Annalisa Saracino - Bari, Italy
Loredana Sarmati - Rome, Italy
Orazio Schillaci - Ministro della Salute, Italy
Giovanna Scroccaro - Regione Veneto; CSE AIFA
Federico Serra - Intergruppo Parlamentare Prevenzione e Controllo Malattie Infettive
Ryan Shields - Chapel Hill, USA
Benedetta Sica - MSD Italia
Carlo Signorelli - Milan, Italy
Robert Skov - Copenaghen, Denmark
Maria Soave - Giornalista RAI, Italy
Pranita Tamma - Philadelphia, USA
Carlo Tascini - Udine, Italy
Elizabeth Tayler - London, UK
Christian Terreaux - OM Pharma
Giusy Tiseo - Pisa, Italy
Carlo Torti - Rome, Italy
Vito Trojano - Bari, Italy
Mario Tumbarello - Siena, Italy
David van Duin - Chapel Hill, USA
Fabio Vecchio - ViiV Healthcare
Silvia Velo - Regione Toscana, Italy
Antonio Vena - Genoa, Italy
Heinam Wertheim - Nijmegen, The Netherlands
Dafna Yahav - Haifa, Israel
Francesco Zaffini - Presidente 10a Commissione Affari Sociali, Italy

Attività obbligatorie

Crediti Formativi (ECM)

L’assegnazione dei crediti è subordinata alla presenza del 90% dei lavori.

Al termine della giornata è obbligatorio la compilazione dei seguenti moduli online:

• questionario di verifica apprendimento ECM;
• scheda valutazione evento;
• scheda fabbisogni formativi;

Cliccando sul bottone ISCRIVITI, se l’utente non ha effettuato login viene rimandato alla relativa pagina all’interno della quale deve obbligatoriamente inserire le credenziali di accesso per potersi iscrivere all’evento,

Se già effettuato login, verrà visualizzata apposita pagina riepilogativa del corso,